José J. Escobar

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.

Riccardo Lencioni, Masatoshi Kudo, Joseph P. Erinjeri et al. · Journal of Clinical Oncology · 2024 · 142 citations

Embolization-eligible Uhcc, Surgical Oncology, Immunology +27

A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema

Amir Rosenblatt, Patricia Udaondo, José Cunha‐Vaz et al. · Ophthalmology · 2019 · 61 citations · Full text

Logistic Regression Analysis of Risk Factors for the Development of Alveolar Osteitis

Diego Halabí, José J. Escobar, Carlos Muñoz et al. · Journal of Oral and Maxillofacial Surgery · 2012 · 49 citations

Alveolar Osteitis, Bone Disease, Epidemiology +7

Chlorhexidine for prevention of alveolar osteitis: a randomised clinical trial

Diego Halabí, José J. Escobar, Cyntia Alvarado et al. · Journal of Applied Oral Science · 2018 · 34 citations · Full text

Antibiotics, Osteopathy, Randomised Clinical Trial +11